Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Keratosis, Actinic 11Pain 3Breast Neoplasms 3Pain, Postoperative 2Non-melanoma Skin Cancer 2Lymphoma, Follicular 2Lung Neoplasms 2Acute Pain 2Urinary Bladder Neoplasms 1Skin Neoplasms 1Respiratory Aspiration 1Prostatic Hyperplasia 1Pneumothorax 1Pleural Neoplasms 1Pleural Effusion 1Photosensitivity Disorders 1Neurofibromatosis 1 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lower Urinary Tract Symptoms 1Hematuria 1Hand-Foot Syndrome 1Empyema, Pleural 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1

Interventions

Rituximab 295Cyclophosphamide 240Peripheral Blood Stem Cell Transplantation 114fludarabine phosphate 110Filgrastim 93Etoposide 85Radiotherapy 81Lenalidomide 79Vincristine 78Prednisone 77Mycophenolic Acid 66Doxorubicin 61Cyclosporine 59Whole-Body Irradiation 58Bendamustine Hydrochloride 58Melphalan 57Tacrolimus 53Busulfan 51fludarabine 50Cytarabine 48obinutuzumab 46Methotrexate 45Antilymphocyte Serum 43Bortezomib 42Methylprednisolone 37Carmustine 37sargramostim 36ibritumomab tiuxetan 32ibrutinib 30Dexamethasone 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Lymphoma, Follicular × Diclofenac × Clear all
NCT01982539 2020-05-07

Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute

Depomed

Phase 4 Completed
25 enrolled 8 charts
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

NCT02287350 2017-07-11

Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain

Depomed

Phase 4 Completed
51 enrolled 45 charts
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡